A detailed history of Fmr LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Fmr LLC holds 141,395 shares of EBS stock, worth $647,589. This represents 0.0% of its overall portfolio holdings.

Number of Shares
141,395
Previous 129,099 9.52%
Holding current value
$647,589
Previous $1.08 Million 25.44%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$7.72 - $11.97 $94,925 - $147,183
12,296 Added 9.52%
141,395 $1.35 Million
Q3 2024

Nov 13, 2024

BUY
$5.72 - $14.77 $82,631 - $213,367
14,446 Added 12.6%
129,099 $1.08 Million
Q2 2024

Aug 13, 2024

BUY
$1.86 - $6.98 $191,656 - $719,226
103,041 Added 887.37%
114,653 $781,000
Q1 2024

May 13, 2024

BUY
$1.5 - $3.41 $567 - $1,288
378 Added 3.36%
11,612 $29,000
Q4 2023

Feb 13, 2024

SELL
$1.82 - $3.16 $211,575 - $367,350
-116,250 Reduced 91.19%
11,234 $26,000
Q3 2023

Nov 13, 2023

BUY
$3.17 - $7.91 $185,226 - $462,189
58,431 Added 84.62%
127,484 $433,000
Q2 2023

Aug 11, 2023

BUY
$7.35 - $13.21 $225,395 - $405,097
30,666 Added 79.89%
69,053 $507,000
Q1 2023

May 11, 2023

SELL
$7.79 - $16.29 $10,906 - $22,806
-1,400 Reduced 3.52%
38,387 $397,000
Q4 2022

Feb 13, 2023

BUY
$11.0 - $21.45 $93,786 - $182,882
8,526 Added 27.27%
39,787 $469,000
Q3 2022

Nov 10, 2022

SELL
$20.09 - $35.8 $3,797 - $6,766
-189 Reduced 0.6%
31,261 $656,000
Q2 2022

Aug 12, 2022

SELL
$27.42 - $43.63 $2,248 - $3,577
-82 Reduced 0.26%
31,450 $977,000
Q1 2022

May 13, 2022

SELL
$36.48 - $52.22 $26.1 Million - $37.4 Million
-715,938 Reduced 95.78%
31,532 $1.29 Million
Q4 2021

Feb 14, 2022

BUY
$33.11 - $55.01 $2.32 Million - $3.86 Million
70,148 Added 10.36%
747,470 $32.5 Million
Q3 2021

Nov 15, 2021

SELL
$50.07 - $66.05 $424,443 - $559,905
-8,477 Reduced 1.24%
677,322 $33.9 Million
Q2 2021

Aug 13, 2021

BUY
$56.61 - $80.46 $38.8 Million - $55.2 Million
685,799 New
685,799 $43.2 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $228M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.